NFKB1 and colorectal cancer: These results suggest that inflammation is a potential target for treatment of some types of colorectal cancer.40 Consistent with the luciferase assay data (Fig. 3c), these GLSF-down-regulated genes are under the control of NF-κB transcription factor.